BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24346602)

  • 1. Ganciclovir for the treatment of congenital cytomegalovirus: what are the side effects?
    Gwee A; Curtis N; Connell TG; Garland S; Daley AJ
    Pediatr Infect Dis J; 2014 Jan; 33(1):115. PubMed ID: 24346602
    [No Abstract]   [Full Text] [Related]  

  • 2. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection.
    Crowley B
    J Antimicrob Chemother; 2002 Sep; 50(3):435-6; author reply 436. PubMed ID: 12205075
    [No Abstract]   [Full Text] [Related]  

  • 3. Congenital cytomegalovirus (CMV) infections: hats off to Alabama.
    Prober CG; Enright AM
    J Pediatr; 2003 Jul; 143(1):4-6. PubMed ID: 12915814
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.
    Amir J; Wolf DG; Levy I
    Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital cytomegalovirus infection treatment.
    Demmler GJ
    Pediatr Infect Dis J; 2003 Nov; 22(11):1005-6. PubMed ID: 14614375
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age.
    Hilgendorff A; Daiminger A; Dangel V; Kreuder J; Geidel C; Reiss I; Enders G
    Klin Padiatr; 2009 Dec; 221(7):448-9. PubMed ID: 20013570
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.
    Lackner A; Acham A; Alborno T; Moser M; Engele H; Raggam RB; Halwachs-Baumann G; Kapitan M; Walch C
    J Laryngol Otol; 2009 Apr; 123(4):391-6. PubMed ID: 18588736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Congenital cytomegalovirus infection. The role of ganciclovir in newborns].
    Aujard Y
    Arch Pediatr; 2014 Feb; 21(2):121-4. PubMed ID: 24377874
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors for ganciclovir-induced thrombocytopenia and leukopenia.
    Matsumoto K; Shigemi A; Ikawa K; Kanazawa N; Fujisaki Y; Morikawa N; Takeda Y
    Biol Pharm Bull; 2015; 38(2):235-8. PubMed ID: 25747982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital CMV- problems with diagnosis.
    Aitken C; Griffiths P
    J Clin Virol; 2009 Jan; 44(1):viii, I. PubMed ID: 19757505
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of congenital cytomegalovirus: where are we now?
    Michaels MG
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):441-8. PubMed ID: 17547508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir therapy for neonates with congenital cytomegalovirus infection.
    Luck S; Sharland M; Griffiths P
    Eur J Pediatr; 2007 Jun; 166(6):633-4. PubMed ID: 17043842
    [No Abstract]   [Full Text] [Related]  

  • 13. Valganciclovir for treatment of congenital cytomegalovirus infection.
    Schulzke S; Bührer C
    Eur J Pediatr; 2006 Aug; 165(8):575-6. PubMed ID: 16534589
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.
    Kimberlin DW; Lin CY; Sánchez PJ; Demmler GJ; Dankner W; Shelton M; Jacobs RF; Vaudry W; Pass RF; Kiell JM; Soong SJ; Whitley RJ;
    J Pediatr; 2003 Jul; 143(1):16-25. PubMed ID: 12915819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with ganciclovir of congenital cytomegalovirus infections].
    Guimarães H; Trindade E; Mateus M; d'Orey C; Almeida A; Martins A; Souto A; Teixeira Santos N
    Arch Pediatr; 1996 Jun; 3(6):609-10. PubMed ID: 8881312
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ganciclovir treatment of congenital cytomegalovirus infection].
    Till A; Rózsai B; Kovács N; Storcz J; Somogyvári F; Deák J; Ertl T; Decsi T
    Orv Hetil; 2006 Apr; 147(13):609-12. PubMed ID: 16623443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
    Whitley RJ; Cloud G; Gruber W; Storch GA; Demmler GJ; Jacobs RF; Dankner W; Spector SA; Starr S; Pass RF; Stagno S; Britt WJ; Alford C; Soong S; Zhou XJ; Sherrill L; FitzGerald JM; Sommadossi JP
    J Infect Dis; 1997 May; 175(5):1080-6. PubMed ID: 9129069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Different dosages Ganciclovir treatment of symptomatic congenital cytomegalovirus infection in neonatal].
    Hong-Bin Z; Feng-Xian Z; Cai-Ping G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):57-9. PubMed ID: 22919757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a 6-week course of ganciclovir therapy effective for chorioretinitis in infants with congenital cytomegalovirus infection?
    Shoji K; Ito N; Ito Y; Inoue N; Adachi S; Fujimaru T; Nakamura T; Nishina S; Azuma N; Saitoh A
    J Pediatr; 2010 Aug; 157(2):331-3. PubMed ID: 20400108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.